期刊文献+

炔雌醇醇质体凝胶的经皮渗透研究 被引量:31

Study on Transdermal Penetration of Ethinyl Estradiol Ethosome Gel
暂未订购
导出
摘要 目的考察醇质体凝胶作为炔雌醇透皮给药载体的可行性。方法采用注入法制备炔雌醇醇质体,进而用卡波姆制备成凝胶,采用TK-6H型透皮扩散试验仪用人皮进行体外经皮渗透实验;以HPLC测定药物含量求算累积渗透量及稳态透皮速率,并测定药物在皮肤表皮和真皮中的滞留量。结果炔雌醇醇质体凝胶的经皮渗透速率(3.59μg.cm-2.h-1)是其水溶液的9.97倍,是体积分数为30%乙醇溶液的1.69倍,是凝胶制剂(含醇量30%)的1.45倍。24 h后皮肤中药物滞留量大小顺序为:醇质体凝胶>体积分数为30%乙醇溶液>凝胶>饱和水溶液。结论醇质体凝胶能提高炔雌醇的透皮速率,增加药物在皮肤内的滞留量。 OBJECTIVE To investigate the feasibility of ethosome gel as transdermal carries of ethinyl estradiol(EE) .METHODS EE was encapsulated in ethosmes composed of phospholipid and ethanol, then ethasomes were incorporated in carbopol gel. Percutaneous permeation of EE was observed using human skin and TK - 6H transdermal diffusion device in vitro. The concentrations of EE in receptor compartment at specified time points were determined by HPLC. The steady flux and the accumulation quantity of ethinyl estradiol in skin were calculated. RESULTS The flux of EE from ethosome gel was 3.59μg·cm^-2·h^-1, which were 9.97, 1.69 and 1.45 times higher than that from saturated aqueous solution, 30% ethanol solution, gel preparation (contain ethanol 30% ), respectively. The subsequence of retention amount in the skin after 24 h was: ethosome gel 〉 30% ethanol solution 〉 gel 〉 drug-saturated aqueous solution. CONCLUSION Ethosome gel is effective for trandermal delivery and increased the EE amount retained in the skin.
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第4期284-286,共3页 Chinese Pharmaceutical Journal
关键词 炔雌醇 凝胶 醇质体 透皮给药系统 ethinyl estradiol gel ethosome transdermal drug delivery
  • 相关文献

参考文献8

  • 1ADRIAN P F,ROMAN S,HANS W M,et al.Transdermal delivery of highly lipophilic drugs:In vitro fluxes of antiestrogens,permeation enhancers,and solvents from liquid formulations[J].Pharm Res,2002,19(5):661-668.
  • 2TOUITOU E.Compositions for applying active substances to or through the skin[P].US,Patent 5,540,934.1996-07-30.
  • 3NAVA D,TOUITOU E.Carriers for skin delivery of trihexyphenidyl HCl:ethosomes vs.liposomes[J].Biomaterials,2000,21:1879-1885.
  • 4DKEIDEK I,TOUITOU E.Transdermal of polypeptides[J].AAPS Pharm Sci,1999,1:S202.
  • 5LODZKI M,GODIN B,RAKOU L,et al.Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model[J].J Controlled Release,2003,93:377-387.
  • 6饶跃峰,郦锋,梁文权.非那甾胺醇质体的体外经皮渗透研究[J].中国药学杂志,2004,39(12):923-925. 被引量:21
  • 7SCHALLER M,KORTING H C.Interaction of liposomes with human skin:the role of the stratum comeum[J].Adv Drug Del Rev,1996,18:303-309.
  • 8TOUITOU E,DAYAN N,BERGELSON L,et al.Ethosomes-novel vesicular carriers for enhanced delivery:characterization and skin penetration properties[J].J Controlled Release,2000,65:403-418.

二级参考文献9

  • 1周彬,曹颖光,袁艳祥,曾引萍.半导体激光穴位照射防治固定义齿修复期颞下颌关节紊乱症的临床观察[J].中华物理医学与康复杂志,2004,26(6):350-351. 被引量:4
  • 2Masson M, Loftsson T, Masson G, et al. Cyclodextrins as permeattion enhancers: some theoretical evaluations and in vitro testing[ J]. J Controlled Release, 1999,59:107.
  • 3Kirjavainen M, Urtti A, Valjakka-Koskela R, et al. Liposome-skin interactions and their effects on the skin permeation of drugs[ J]. Eur J Pharma Sci, 1999,7:279.
  • 4Touitou E, Dayan N, Bergelson L, et al.Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties [ J ]. J Controlled Release, 2000,65: 403.
  • 5Dayan N, Touitou E. Carriers for skin delivery of trihexyphenidyl HCl:ethosomes vs. liposomes[J].Biomaterials, 2000,21:1879.
  • 6Gormley GJ. Finasteride: a clinical review[J]. Biomed Pharmacother,1995,49:319.
  • 7Kaufman D,Androgens and alopecia[J] .Mol Cell Endocrinol,2002,198:89.
  • 8Schaller M, Korting HC. Interaction of liposomes with human skin:the role of the stratum comeum[J] .Adv Drug Del Rev, 1996,18:303.
  • 9Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery[J]. Eur J Pharma Sci ,2001,14:101.

共引文献20

同被引文献374

引证文献31

二级引证文献208

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部